These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 36238288)

  • 21. Panels of circulating microRNAs as potential diagnostic biomarkers for breast cancer: a systematic review and meta-analysis.
    Nguyen THN; Nguyen TTN; Nguyen TTM; Nguyen LHM; Huynh LH; Phan HN; Nguyen HT
    Breast Cancer Res Treat; 2022 Nov; 196(1):1-15. PubMed ID: 36085533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of microRNA expression profiling identifies miR-155 and miR-155* as potential diagnostic markers for active tuberculosis: a preliminary study.
    Wu J; Lu C; Diao N; Zhang S; Wang S; Wang F; Gao Y; Chen J; Shao L; Lu J; Zhang X; Weng X; Wang H; Zhang W; Huang Y
    Hum Immunol; 2012 Jan; 73(1):31-7. PubMed ID: 22037148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic evaluation of line probe assays for the diagnosis of tuberculosis and drug-resistant tuberculosis.
    Lin M; Chen YW; Li YR; Long LJ; Qi LY; Cui TT; Wu SY; Lin JY; Wu T; Yang YC; Yuan WH; Wu GY; Lan QW; Liu JQ; Li YP; Yu ZY; Guo XG
    Clin Chim Acta; 2022 Aug; 533():183-218. PubMed ID: 35792161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomarkers for diagnosis of childhood tuberculosis: A systematic review.
    Togun TO; MacLean E; Kampmann B; Pai M
    PLoS One; 2018; 13(9):e0204029. PubMed ID: 30212540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tuberculosis-Associated MicroRNAs: From Pathogenesis to Disease Biomarkers.
    Sinigaglia A; Peta E; Riccetti S; Venkateswaran S; Manganelli R; Barzon L
    Cells; 2020 Sep; 9(10):. PubMed ID: 32987746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miRNAs in immune responses to Mycobacterium tuberculosis infection.
    Yang T; Ge B
    Cancer Lett; 2018 Sep; 431():22-30. PubMed ID: 29803788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The meta-analysis for ideal cytokines to distinguish the latent and active TB infection.
    Wei Z; Li Y; Wei C; Li Y; Xu H; Wu Y; Jia Y; Guo R; Jia J; Qi X; Li Z; Gao X
    BMC Pulm Med; 2020 Sep; 20(1):248. PubMed ID: 32948170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Association between Circulating microRNAs and the Risk of Active Disease Development from Latent Tuberculosis Infection: a Nested Case-Control Study.
    Xin H; Cao X; Du Y; Yan J; He R; Liu Z; Zhang H; He Y; Zhang B; Wang D; Guan L; Shen F; Feng B; Quan Z; He Y; Liu J; Jin Q; Pan S; Gao L
    Microbiol Spectr; 2022 Jun; 10(3):e0262521. PubMed ID: 35435753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accuracy of circulating microRNAs in diagnosis of sepsis: a systematic review and meta-analysis.
    Shen X; Zhang J; Huang Y; Tong J; Zhang L; Zhang Z; Yu W; Qiu Y
    J Intensive Care; 2020 Nov; 8(1):84. PubMed ID: 33292630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
    Steingart KR; Sohn H; Schiller I; Kloda LA; Boehme CC; Pai M; Dendukuri N
    Cochrane Database Syst Rev; 2013 Jan; (1):CD009593. PubMed ID: 23440842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening and identification of six serum microRNAs as novel potential combination biomarkers for pulmonary tuberculosis diagnosis.
    Zhang X; Guo J; Fan S; Li Y; Wei L; Yang X; Jiang T; Chen Z; Wang C; Liu J; Ping Z; Xu D; Wang J; Li Z; Qiu Y; Li JC
    PLoS One; 2013; 8(12):e81076. PubMed ID: 24349033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The diagnostic performance of novel skin-based in-vivo tests for tuberculosis infection compared with purified protein derivative tuberculin skin tests and blood-based in vitro interferon-γ release assays: a systematic review and meta-analysis.
    Krutikov M; Faust L; Nikolayevskyy V; Hamada Y; Gupta RK; Cirillo D; Mateelli A; Korobitsyn A; Denkinger CM; Rangaka MX
    Lancet Infect Dis; 2022 Feb; 22(2):250-264. PubMed ID: 34606768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic accuracy of Mycobacterium tuberculosis cell-free DNA for tuberculosis: A systematic review and meta-analysis.
    Yu G; Shen Y; Ye B; Shi Y
    PLoS One; 2021; 16(6):e0253658. PubMed ID: 34161399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The miRNA Mirage: How Close Are We to Finding a Non-Invasive Diagnostic Biomarker in Endometriosis? A Systematic Review.
    Agrawal S; Tapmeier T; Rahmioglu N; Kirtley S; Zondervan K; Becker C
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance of diagnostic and predictive host blood transcriptomic signatures for Tuberculosis disease: A systematic review and meta-analysis.
    Mulenga H; Zauchenberger CZ; Bunyasi EW; Mbandi SK; Mendelsohn SC; Kagina B; Penn-Nicholson A; Scriba TJ; Hatherill M
    PLoS One; 2020; 15(8):e0237574. PubMed ID: 32822359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene expression profiling identifies candidate biomarkers for active and latent tuberculosis.
    Lee SW; Wu LS; Huang GM; Huang KY; Lee TY; Weng JT
    BMC Bioinformatics; 2016 Jan; 17 Suppl 1(Suppl 1):3. PubMed ID: 26818387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. microRNAs as novel diagnostic biomarkers in endometriosis patients: a systematic review and meta-analysis.
    Zafari N; Bahramy A; Majidi Zolbin M; Emadi Allahyari S; Farazi E; Hassannejad Z; Yekaninejad MS
    Expert Rev Mol Diagn; 2022 Apr; 22(4):479-495. PubMed ID: 34304687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic value of microRNAs in active tuberculosis based on quantitative and enrichment analyses.
    Yao S; Liu B; Hu X; Tan Y; Liu K; He M; Wu B; Ahmad N; Su X; Zhang Y; Yi M
    Diagn Microbiol Infect Dis; 2024 Apr; 108(4):116172. PubMed ID: 38340483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The diagnostic accuracy of the GenoType(®) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs.
    Theron G; Peter J; Richardson M; Barnard M; Donegan S; Warren R; Steingart KR; Dheda K
    Cochrane Database Syst Rev; 2014 Oct; (10):CD010705. PubMed ID: 25353401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salivary miRNAs as auxiliary liquid biopsy biomarkers for diagnosis in patients with oropharyngeal squamous cell carcinoma: a systematic review and meta-analysis.
    Nguyen H; Nonaka T
    Front Genet; 2024; 15():1352838. PubMed ID: 38528913
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.